Cancer false alarm may give false sense of security
the ONA take:
According to a new study published in the journal BMJ Open, Cancer Research UK researchers have found that having a cancer false alarm could dissuade people from further investigating cancer symptoms they may develop in the future.
Researchers from the Health Behaviour Research Centre at University College London in United Kingdom conducted a review of 19 international studies to assess the effect of a cancer false alarm.
They found that patients may delay seeking help from a healthcare professional for new or recurrent symptoms if they feel that it is not cancer because of a previous false alarm or if they feel unsupported by the healthcare system.
Researchers found that if patients felt unsupported previously, there is a concern that the healthcare professional will think the patient is making a fuss out of nothing.
Results also showed that insufficient education at the time of the cancer false alarm made the patients feel like the doctor would not be able to help at the time of new onset of symptoms.
The findings suggest that patients should not have a false sense of security after experiencing a cancer false alarm, and that patients should still seek help from a healthcare professional if the experience new or recurrent symptoms.
Having a cancer false alarm could dissuade people from further investigating cancer symptoms they may develop in the future.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|